MPs find no evidence that Cancer Drugs Fund was spent wiselyBMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i755 (Published 05 February 2016) Cite this as: BMJ 2016;352:i755
- Nigel Hawkes
A total of £1.27bn (€1.7bn; $1.9bn) has so far been spent on the Cancer Drugs Fund in England, but no data exist to show whether it has been spent wisely, the House of Commons Public Accounts Committee says in a new report.1
Despite the Department of Health noting when the fund was set up in 2010 that it was important to collect clinical outcomes from the drugs it pays for, few data exist. The department encouraged NHS trusts to collect data but did not require them to do so. When NHS England took over the fund in April 2014 it made data collection mandatory, but the committee still found gaps for 2014-15, with 93% of records having no summary of outcomes.
The health department and NHS England “have not managed the fund effectively” the …